LACTOSE (INDIA)
Back to Balance Sheet
|
LACTOSE (INDIA) Last 5 Year Total Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹45 Cr | ₹25 Cr | ₹26 Cr | ₹15 Cr | ₹12 Cr |
What is the latest Total Current Liabilities ratio of LACTOSE (INDIA) ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹45 Cr |
| Mar2024 | ₹25 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹15 Cr |
| Mar2021 | ₹12 Cr |
How is Total Current Liabilities of LACTOSE (INDIA) Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹45 Cr | 76.74 | |
| Mar2024 | ₹25 Cr | -4.04 | |
| Mar2023 | ₹26 Cr | 77.51 | |
| Mar2022 | ₹15 Cr | 28.26 | |
| Mar2021 | ₹12 Cr | - | |
Compare Total Current Liabilities of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹161.3 Cr | -1.4% | 10.8% | -30.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 2.8% | 6.7% | 2.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.9% | -0.5% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 0.1% | 3.4% | 15.8% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 1.8% | -3.2% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 2.7% | 0.4% | 3.4% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | -1.4% |
10.8% |
-30.6% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses